Ahava freezes IPO

By SHARON WROBEL
October 25, 2007 07:15

Dead Sea Laboratories CEO Yaacov Ellis said Ahava was showing excellent business results and putting the IPO on hold would enable the company to maximize its value at a better time on the market.




Dead Sea Laboratories Ltd., the manufacturer of Ahava Dead Sea products, on Wednesday decided to postpone its planned initial public offering on London's Alternative Investment Market because of current market conditions in the UK and the US. Dead Sea Laboratories CEO Yaacov Ellis said Ahava was showing excellent business results and putting the IPO on hold would enable the company to maximize its value at a better time on the market.


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Israel Weather
  • 9 - 17
    Beer Sheva
    12 - 16
    Tel Aviv - Yafo
  • 6 - 12
    Jerusalem
    9 - 14
    Haifa
  • 11 - 22
    Elat
    12 - 16
    Tiberias